General SHASTA trials show substantial triglyceride reductions with plozasiranBy Healthcare Propulsion StaffAugust 31, 20260 Plozasiran treatment resulted in substantial reductions in triglyceride levels in patients with severe hypertriglyceridemia after one year, according to…
Tech Shape Memory secures $10m to advance aortic clinical trialsBy Healthcare Propulsion StaffAugust 24, 20260 Shape Memory Medical’s technology is being used in ongoing aortic studies. Credit: sweet_tomato / Shutterstock.com. Shape Memory Medical has raised…
